Tower Research Capital (TRC)’s Elevai Labs ELAB Stock Holding History

Tower Research Capital (TRC)’s Portfolio ELAB Stock Details ELAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$773	Sell	129 -2	-2%	-$26	﹤0.01%	4780
2025 Q4	$4.64K	Buy	131 +112	+589%	+$13.3K	﹤0.01%	4196
2025 Q3	$2.45K	Buy	19 +10	+111%	+$1.6K	﹤0.01%	4627
2025 Q2	$1.62K	Sell	9 -5	-36%	-$1.08K	﹤0.01%	4771
2025 Q1	$5.54K	Buy	14 +13	+1,300%	+$11.4K	﹤0.01%	4114
2024 Q4	$909	Buy	+1	New	+$5.2K	﹤0.01%	5139
2024 Q3	–	Hold	0	–	–	–	4876

Other funds holding ELAB

Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Schonfeld Strategic Advisors New York $12.3B AUM 37.17% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return